Medical device maker Ekos acquired in $180M deal

ekos1111

Ekos, a Bothell medical device maker whose catheter-based ultrasound devices are used to break up blood clots in legs, has been acquired by British pharmaceutical company BTG for $180 million. The deal also includes up to $40 million in additional payouts if milestones are met. In addition to Ekos, BTG also agreed to purchased Nordion’s… Read More…

Bruce Montgomery biotech startup Cardeas Pharma raises $34 million

montgomery1

It has been a good week for the Seattle life sciences community. On Monday, Seattle genomics tool maker NanoString Technologies filed for an initial public offering that could raise up to $86 million. Now, comes word that Cardeas Pharma Corporation, a biopharmaceutical company led by Seattle biotech veteran Bruce Montgomery, has raised $34 million in funding…. Read More…

Frazier buys pharmaceutical packaging company AndersonBrecon

packaging-drugs

Seattle venture capital firm Frazier Healthcare has joined with Philadelphia-based Packaging Coordinators to purchase AndersonBrecon, a leading contract pharmaceutical packing company. The unit had previously been owned by health services giant AmerisourceBergen Corporation. Packaging Coordinators is a portfolio company of Frazier, and the newly-combined entity will operate under the Packaging Coordinators name. “PCI has been on an aggressive… Read More…

BeatBio gets $2.5M for new ‘super fuel’ that boosts pumping power of heart muscles

beatbio1111

BeatBio, a Seattle life sciences startup led by former Vulcan Capital managing director Michael Kranda and former VieVax CTO Gregory Mahairas, has raised $2.5 million in seed funding from CET Capital Partners, the W Fund and others. The new funds will be used to move the company’s gene therapy product into clinical trials, an experimental… Read More…

Microsoft’s Craig Mundie joins board of Institute for Systems Biology

Craig Mundie. (Microsoft file photo)

We’re getting a better idea of how longtime Microsoft executive Craig Mundie is going to spend some of his time after he retires from the software giant next year. Mundie, the former chief research and strategy officer at Microsoft who now serves as an advisor to Steve Ballmer, was just named to the board of the… Read More…

Theraclone raises $14M to ID rare human antibodies that could be used to fight disease

theraclone22

Seattle biotechnology company Theraclone Sciences has raised an additional $8 million in equity financing and $6 million in debt, bringing total investment in its series B funding to $50 million. Investors in the round included ARCH Venture Partners, Canaan Partners, MPM Capital, Healthcare Ventures, Alexandria Real Estate Equities, Amgen Ventures, Versant Ventures and Zenyaku Kogyo. “Theraclone… Read More…

Blaze Bioscience raises $8.5M to help surgeons pinpoint cancer cells with ‘tumor paint’

Jim Olson

Seattle biotechnology startup Blaze Bioscience has raised $8.5 million to continue developing technologies that  are designed to help surgeons more easily identify cancer cells in the body. Total funding in the company, with operations in the South Lake Union area of Seattle, now stands at $9.8 million. Blaze said that the money came from individual… Read More…

Innovative Pulmonary changes name, raises $10M and moves to Minnesota

holaira11

Innovative Pulmonary Solutions has a new name, a new round of cash and a new headquarters. The medical device company announced today that it has changed its name to Holaira and opened a new headquarters in Plymouth, Minnesota. It also raised $10 million from existing investors, including Advanced Technology Ventures, Morgenthaler Ventures, Split Rock Partners, and… Read More…

OncoGenex finance chief resigns after ‘personal relationship’ develops with CEO

Michelle Burriss

Michelle Burris, the chief financial officer at Bothell biotechnology company OncoGenex Pharmaceuticals, has resigned from her post after disclosing a “developing personal relationship” with CEO Scott Cormack. After the relationship was disclosed to the board, the company determined that Burris should hand over her executive duties to others in the company. She will continue to serve… Read More…

NanoString lands $15.3M for genetic analysis system

nanostring

NanoString Technologies continues to rake in new capital, announcing today that it has raised $15.3 million from Morgan Stanley Expansion Capital and AllianceBernstein Alternative Investment Management Group. Existing investors, including Clarus Ventures, Draper Fisher Jurvetson, OVP Venture Partners, GE healthymagination Fund and BioMed Ventures, also participated in the financing. The deal follows a $20 million financing round… Read More…